Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Prepaid Assets (2017 - 2025)

Puma Biotechnology's Prepaid Assets history spans 9 years, with the latest figure at $117000.0 for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 96.76% year-over-year to $117000.0; the TTM value through Dec 2025 reached $117000.0, down 96.76%, while the annual FY2025 figure was $117000.0, 96.76% down from the prior year.
  • Prepaid Assets reached $117000.0 in Q4 2025 per PBYI's latest filing, down from $230000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $11.3 million in Q2 2021 to a low of $73000.0 in Q2 2025.
  • Average Prepaid Assets over 5 years is $3.0 million, with a median of $1.8 million recorded in 2022.
  • The largest YoY upside for Prepaid Assets was 1987.06% in 2025 against a maximum downside of 96.76% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $9.0 million in 2021, then tumbled by 34.31% to $5.9 million in 2022, then fell by 25.16% to $4.4 million in 2023, then dropped by 18.29% to $3.6 million in 2024, then plummeted by 96.76% to $117000.0 in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Prepaid Assets are $117000.0 (Q4 2025), $230000.0 (Q3 2025), and $73000.0 (Q2 2025).